The Utility of PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men With High GC Decipher Test Scores: A Sub-aim of the VANDAAM Study (MCC #18523)
Phase of Trial: Phase II/III
Latest Information Update: 05 Dec 2019
Price : $35 *
At a glance
- Drugs 18F DCFPyL (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 17 Oct 2019 Status changed from not yet recruiting to recruiting.
- 09 Aug 2019 Planned initiation date changed from 1 Sep 2019 to 1 Nov 2019.
- 09 Jul 2019 Planned initiation date changed from 1 Jun 2019 to 1 Sep 2019.